Leid M, Franklin P H, Murray T F
College of Pharmacy, Oregon State University, Corvallis.
Eur J Pharmacol. 1988 Feb 16;147(1):141-4. doi: 10.1016/0014-2999(88)90644-9.
We have used the antagonist radioligand 8-cyclopentyl-1,3-[3H]dipropylxanthine to label adenosine recognition sites in porcine atrial membranes. 8-Cyclopentyl-1,3-[3H]dipropylxanthine bound saturably, reversibly and with high affinity to an apparently homogeneous population of recognition sites with a Bmax of 32.0 +/- 0.9 fmol/mg protein and a KD of 0.394 +/- 0.049 nM. Prototypic adenosine receptor agonists inhibited the specific binding of 8-cyclopentyl-1,3-[3H]dipropylxanthine in a manner consistent with the labeling of an A1 adenosine receptor. 8-Cyclopentyl-1,3-[3H]dipropylxanthine appears to be a valuable antagonist radioligand for the characterization of cardiac adenosine receptors.
我们使用拮抗剂放射性配体8-环戊基-1,3-[³H]二丙基黄嘌呤来标记猪心房膜中的腺苷识别位点。8-环戊基-1,3-[³H]二丙基黄嘌呤以饱和、可逆且高亲和力的方式与明显均一的识别位点群体结合,Bmax为32.0±0.9 fmol/mg蛋白质,KD为0.394±0.049 nM。典型的腺苷受体激动剂以与A1腺苷受体标记一致的方式抑制8-环戊基-1,3-[³H]二丙基黄嘌呤的特异性结合。8-环戊基-1,3-[³H]二丙基黄嘌呤似乎是用于表征心脏腺苷受体的一种有价值的拮抗剂放射性配体。